Article Information
History
- August 21, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jennifer A. Rathe1,2,#,
- Emily A. Hemann1,#,
- Julie Eggenberger1,
- Zhaoqi Li3,
- Megan L. Knoll1,
- Caleb Stokes1,2,
- Tien-Ying Hsiang1,
- Jason Netland1,
- Kennidy Takehara1,
- Marion Pepper1 and
- Michael Gale Jr.1,*
- 1Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington
- 2Department of Pediatric Infectious Disease, Seattle Children’s Hospital / University of Washington
- 3Department of Statistics, University of Washington
- Current Affiliation Emily A. Hemann: Department of Microbial Infection and Immunity, The Ohio State University
- ↵*Corresponding author: Michael Gale, Jr. Email: mgale{at}uw.edu Building E (SLU 3.1) 750 Republican St. Room E360 | Box 35809 Seattle, WA 98109
↵# These authors contributed equally to this study
Posted August 21, 2020.
SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing
